Literature DB >> 17889662

Human telomerase RNA accumulation in Cajal bodies facilitates telomerase recruitment to telomeres and telomere elongation.

Gaël Cristofari1, Emem Adolf, Patrick Reichenbach, Katarzyna Sikora, Rebecca M Terns, Michael P Terns, Joachim Lingner.   

Abstract

Telomerase is required for telomere maintenance and is responsible for the immortal phenotype of cancer cells. How telomerase is assembled and reaches telomeres in the context of nuclear architecture is not understood. Recently, the telomerase RNA subunit (hTR) was shown to accumulate in Cajal bodies (CBs), subnuclear structures implicated in ribonucleoprotein maturation. However, the functional relevance of this localization for telomerase was unknown. hTR localization to CBs requires a short sequence motif called the CAB box. Here, we reconstitute telomerase in human cells and determine the effects of CAB box mutations on telomere biology. We demonstrate that mutant hTR, which fails to accumulate in CBs, is fully capable of forming catalytically active telomerase in vivo but is strongly impaired in telomere extension. The functional deficiency is accompanied by a decreased association of telomerase with telomeres. Collectively, these data identify subnuclear localization as an important regulatory mechanism for telomere length homeostasis in human cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889662     DOI: 10.1016/j.molcel.2007.07.020

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  91 in total

1.  Telomerase recruitment requires both TCAB1 and Cajal bodies independently.

Authors:  J Lewis Stern; Katherine G Zyner; Hilda A Pickett; Scott B Cohen; Tracy M Bryan
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

2.  RNA/DNA hybrid binding affinity determines telomerase template-translocation efficiency.

Authors:  Xiaodong Qi; Mingyi Xie; Andrew F Brown; Christopher J Bley; Joshua D Podlevsky; Julian J-L Chen
Journal:  EMBO J       Date:  2011-10-11       Impact factor: 11.598

3.  The 5' guanosine tracts of human telomerase RNA are recognized by the G-quadruplex binding domain of the RNA helicase DHX36 and function to increase RNA accumulation.

Authors:  Alec N Sexton; Kathleen Collins
Journal:  Mol Cell Biol       Date:  2010-12-13       Impact factor: 4.272

4.  Specificity and stoichiometry of subunit interactions in the human telomerase holoenzyme assembled in vivo.

Authors:  Emily D Egan; Kathleen Collins
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

5.  Dynamics of Human Telomerase Holoenzyme Assembly and Subunit Exchange across the Cell Cycle.

Authors:  Jacob M Vogan; Kathleen Collins
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

6.  Architecture of human telomerase RNA.

Authors:  Qi Zhang; Nak-Kyoon Kim; Juli Feigon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

7.  Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies.

Authors:  M A Trudeau; J M Y Wong
Journal:  Curr Pharmacogenomics Person Med       Date:  2010-03-01

8.  A self-regulating template in human telomerase.

Authors:  Andrew F Brown; Joshua D Podlevsky; Xiaodong Qi; Yinnan Chen; Mingyi Xie; Julian J-L Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

9.  A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis.

Authors:  Andrew S Venteicher; Eladio B Abreu; Zhaojing Meng; Kelly E McCann; Rebecca M Terns; Timothy D Veenstra; Michael P Terns; Steven E Artandi
Journal:  Science       Date:  2009-01-30       Impact factor: 47.728

10.  Telomerase reverse transcriptase is required for the localization of telomerase RNA to cajal bodies and telomeres in human cancer cells.

Authors:  Rebecca L Tomlinson; Eladio B Abreu; Tania Ziegler; Hinh Ly; Christopher M Counter; Rebecca M Terns; Michael P Terns
Journal:  Mol Biol Cell       Date:  2008-06-18       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.